Outstanding increase in tumor-to-background ratio over time allows tumor localization by [<sup>89</sup>Zr]Zr-PSMA-617 PET/CT in early biochemical recurrence of prostate cancer. This evidence concerns the gene FOLH1 and prostate carcinoma.